ShellStockReview.com

Member Login

Forum - Latest Posts

  • No posts to display.
Welcome, Guest
Username: Password: Remember me

TOPIC: CYON - Cytation Corp. reverse merger

CYON - Cytation Corp. reverse merger 13 years 1 week ago #958

  • Guest
  • Guest's Avatar
[Deer Valey HomebuildersInc. financials released...]
Basically, for 2005:

Assets: $8mil
Debts: $5.2mil
Revenues: $35.7mil
Net Income: $3.3mil






DEER VALLEY HOMEBUILDERS, INC.
BALANCE SHEETS

DECEMBER 31,
2005 2004

<S> <C> <C>
ASSETS
CURRENT ASSETS:
Cash and Cash Equivalents $ 2,931,263 $ 1,563,818
Certificate of Deposit 151,418 --
Accounts Receivable 2,140,404 1,064,518
Other Receivable 7,500 1,000
Inventories 1,115,558 687,110
Prepayments and Other Current Assets 52,419 48,916

Total Current Assets 6,398,562 3,365,362


Property, Plant and Equipment
Property, Plant and Equipment at Cost 1,814,683 1,705,470
Less: Accumulated Depreciation ( 203,152) ( 84,211)

Net Property, Plant and Equipment 1,611,531 1,621,259


TOTAL ASSETS $ 8,010,093 $ 4,986,621
============= ==============

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Current Maturities of Long-Term Debt $ 55,716 $ 58,190
Accounts Payable 1,166,020 496,821
Accounts Payable under Dealer Incentive Programs 340,432 108,056
Estimated Warranties 750,000 550,000
Compensation and Related Accruals 413,939 271,121
Accrued Stockholder Distributions 925,000 545,540
Other Accrued Expenses 228,832 67,967

Total Current Liabilities 3,879,939 2,097,695


Long-Term Debt, Net of Current Maturities 1,367,148 1,442,578

Total Long-Term Debt 1,367,148 1,442,578


Commitments and Contingencies (Note 9)

Stockholders' Equity:
Common Stock, $1.00 Par Value, 1,000 shares authorized,
940 shares and 1,000 shares issued, and outstanding, respectively 940 1,000
Paid-In Capital 1,033,060 1,099,000
Retained Earnings 1,729,006 412,348

2,763,006 1,512,348

Treasury Stock, at Cost; 60 shares -- ( 66,000)

Total Stockholders' Equity 2,763,006 1,446,348


TOTAL LIABILITES AND STOCKHOLDERS' EQUITY $ 8,010,093 $ 4,986,621
============= ==============
</TABLE>

See Reports of Independent Registered Public Accounting Firm and Notes to
Financial Statements

3
<PAGE>

<TABLE>
<CAPTION>
DEER VALLEY HOMEBUILDERS, INC.
STATEMENT OF OPERATIONS

FOR YEARS ENDED DECEMBER 31,
2005 2004

<S> <C> <C>
Net Revenue $ 35,717,073 $ 15,394,215

Cost of Sales 29,292,051 12,769,267


Gross Profit 6,425,022 2,624,948


Selling, General and Administrative 2,996,023 1,559,333


Operating Income 3,428,999 1,065,615


Other Income (Expense)
Interest Expense ( 74,904) ( 55,109)
Interest Income 12,563 --

( 62,341) ( 55,109)

Net Income $ 3,366,658 $ 1,010,506
================= ===============

Basic and Diluted Net Income Per Share $ 3,574 $ 1,011
================= ===============

Weighted Average Shares Outstanding 942 1,000
================= ===============

SEC Filing
The administrator has disabled public write access.

CYON - Cytation Corp. reverse merger 13 years 2 months ago #944

  • Guest
  • Guest's Avatar
[Opening of a Second Manufacturing Facility...]
Company News

CYON:US Cytation Corp
More on CYON:US NewsDetailed QuoteCharts


Cytation Corporation and Deer Valley Homebuilders Announces the
Opening of a Second Manufacturing Facility in Alabama

TAMPA, Fla.--(BUSINESS WIRE)--Jan. 27, 2006 Cytation Corporation (OTCBB:CYON), ("Cytation") and its wholly owned subsidiary, Deer Valley Homebuilders, Inc. ("Deer Valley"), are proud to announce the proposed opening of Deer Valley's second plant (Plant II). This manufactured housing plant, to be located at 7668 Highway 278 in Sulligent, Alabama, will operate as an extension of Deer Valley's main plant (Plant I) located in nearby Guin, AL.

Charles G. Masters, Chief Executive Officer of Cytation, stated: "The new plant will produce the same heavy built, affordable housing units for which Deer Valley Homebuilders, Inc. is renowned. Shipments of finished homes from the Plant II facility are expected to begin in late February 2006."

According to Joel Logan, President of Deer Valley Homebuilders, Inc., "Demand for heavy built, quality affordable housing has necessitated the anticipated expansion. We are very pleased that this expansion will allow us to better provide new homes to our valued retailers and homebuyers." Chet Murphree, VP of Marketing, stated: "Our entire staff extends sincerest appreciation to some of the finest retailers in the industry. The outstanding performance of our dealers in 2005 and 2006 continues to drive our dramatic sales growth."

About Deer Valley Homebuilders, Inc.

Deer Valley Homebuilders, Inc., a manufactured home builder headquartered in Guin, Alabama, is dedicated to offering exceptionally high quality homes that are delivered with a sense of warmth, friendliness and personal pride. The management of the company has over 125 years of combined industry experience from various backgrounds including general management, production, sales customer service and finance. Additional information can be found at http://www.deervalleyhb.com .

The corporate offices of Cytation Corporation are located at 4902 Eisenhower Blvd., Suite 185, Tampa, FL 33634. Questions may be addressed to Charles G. Masters, President, at (813) 885-5998.

http://quote.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=CYON:US&sid=aFd_OMU7Kajo
The administrator has disabled public write access.

CYON - Cytation Corp. reverse merger 13 years 2 months ago #943

  • Guest
  • Guest's Avatar
[CYON update...]
New filing for CYON that contains info about the new private company that is coming into the CYON shell.

Some highlights from the 8K SEC Filing:

Deer Valley was launched in January, 2004, and has quickly become a leading manufacturer of factory built homes in the southeastern and south central housing markets in the United States. As of the date of this Report, we manufacture all of our factory built homes from a single manufacturing facility located in Guin, Alabama. We rely upon a team of regional sales directors and approximately 110 independent dealers to market our manufactured homes in over 80 retail locations. As of the date of this Report, we are selling our manufactured homes in 14 states through our network of independent dealers and retail centers.

Valley's backlog of orders for manufactured homes as of October 1, 2005 was $8,925,000 million.

At December 31, 2005, Deer Valley sold manufactured homes through approximately 110 independent dealers at approximately 80 retail locations in 14 states, principally in the southeastern and south-central United States.

REVENUES. Overall net revenues for the year ended December 31, 2004 were $15,394,215. In addition, overall net revenues for the nine month period ending October 1, 2005 were $24,023,661, as compared to net revenues of $8,820,069 for the nine month period ending September 25, 2004. The increase of $15,203,592 is due to increased sales and production of homes which increased from 661 floors in 2004 to 1,381 in 2005.

NET INCOME (LOSS). The net income for the year ended December 31, 2004 was $1,010,506. The net income for the nine month period ending October 1, 2005 was $2,123,844, as compared to the net income of approximately $420,767 for the nine month period ending September 25, 2004. The increase in net income for the nine month period ending October 1, 2005 is primarily due to increased sales and profitability of Deer Valley's operations.

http://www.sec.gov/Archives/edgar/data/95047/000121478206000013/cytation8k.txt

Not a recommendation to buy, sell, or hold CYON. I own shares in CYON purchased on the open market.
The administrator has disabled public write access.

CYON - Cytation Corp. reverse merger 13 years 3 months ago #942

  • Guest
  • Guest's Avatar
[CYON latest Reverse Merger]
CYTATION CORPORATION ACQUIRES DEER VALLEY HOMEBUILDERS, INC. AND COMPLETES SECURITIES OFFERING

January 18, 2006 08:00:00 AM ET

Cytation Corporation (“Cytation” or the “Company”) (OTCBB: CYON), its wholly owned subsidiary DeerValley Acquisitions Corp. (“DeerValley Acquisitions”) and Deer Valley Homebuilders, Inc. (“Deer Valley”) announced today that they have raised funding in excess of $6,500,000 and closed a definitive Securities Purchase and Share Exchange Agreement, providing for the acquisition by Cytation/ DeerValley Acquisitions of all the issued and outstanding shares of Deer Valley Homebuilders, Inc.

Upon completion of the acquisition of Deer Valley, Charles G. Masters was elected to serve as Chief Executive Officer and President and was named as a director of Cytation.

Also in conjunction with the transaction, Cytation has concluded a private placement with institutional and other accredited investors in excess of $5,000,000. The Company issued Series A Convertible Preferred Stock, Series A Warrants, and Series B Warrants to the group of investors. Also in conjunction with the transaction, Cytation has concluded a private placement of debt with an institutional investor in the amount of $1,500,000. The Company issued a debenture with warrants to the investor. Midtown Partners & Co., LLC (“Midtown Partners”) acted as the sole placement agent in these transactions.

According to Charles G. Masters, President and Chief Executive Officer of Cytation, “We are excited that we have completed the Securities Purchase and Share Exchange Agreement. Being public should allow us to execute our 2006 plan. We are very excited that Joel S. Logan II and his entire existing management team will continue to run the operations of Deer Valley after the completion of this transaction.”

“We are pleased that our acquisition of Deer Valley was completed in a timely fashion,” notes Richard Fisher, former Chairman of Cytation Corporation. “We believe that the acquisition of Deer Valley is in the best interest of all Cytation shareholders.”

About Deer Valley Homebuilders, Inc.
Deer Valley Homebuilders, Inc. is a manufactured home builder located in Guin, Alabama dedicated to offering the highest quality of homes that are delivered with a sense of warmth, friendliness and personal pride. The management of the company has over 125 years of combined industry experience from various backgrounds including general management, production, sales customer service and finance. Additional information can be found at http://www.deervalleyhb.com.

SEC Filing
The administrator has disabled public write access.

CYON - Cytation Corp. reverse merger 14 years 5 days ago #874

  • Guest
  • Guest's Avatar
[Some info on EVON]
Company Name Evolve Oncology
Ticker EVON

Pipeline Pre Clinical: 4 Phase I: 2 Phase II: 3 Phase III: 1 At Market: 0


Evolve Oncology is developing products for the treatment of breast cancer, leukaemia and multiple cancer treatments including lymphomas, melanomas and gastric cancer. Four potential blockbuster products in development. Management has a track record of successful development and commercialization with lead product targeting a largely unmet need as it has potential usage in patients unable to tolerate chemotherapy. Evolve Oncology will further develop its portfolio of product to build value prior to partnering. Company will in-license further identified oncology products and use its network to enhance value and commercialize.

Link
The administrator has disabled public write access.

CYON - Cytation Corp. reverse merger 14 years 1 week ago #869

  • Guest
  • Guest's Avatar
[CYON - Cytation Corp. reverse merger]
CYON was on the Profile List back in 2002, but was removed after they started their "Dividend Distribution Program." Now they are changing direction with a reverse merger with EVON, an Oncology company. They also announced a 2.5 for 1 forward split of the stock.

They released the following 8K today:

April 8, 2005, the Company entered into a binding letter of intent with Evolve Oncology, Inc. ("Evolve") (Pink Sheets: "EVON") to effect a merger with Evolve. The Company will be the surviving corporation. Under the proposed merger, the Company would authorize additional shares of common stock to be issued in the transaction, declare a 2.5 for forward stock split, and issue to Evolve's stockholders approximately 20,800,000 newly issued shares of its common stock. Evolve agreed to assume and to pay approximately $115,000 of the Company's liabilities at the closing of the transaction. After the transaction, stockholders of Evolve would own approximately 95% of the total issued and outstanding common stock of the Company.

Evolve is developing products for the treatment of breast cancer, leukemia and multiple cancer treatments including lymphomas, melanomas and gastric cancer.

8k Filing

NOT A RECCOMENDATION TO BUY, SELL, OR HOLD CYON. I own shares in CYON purchased on the open market.
The administrator has disabled public write access.
Moderators: Editor
Time to create page: 0.273 seconds